News Archive

/static/apps/cms/news/1488/Svenneti-e1693245417513.jpg

Breakthrough in Defining pre-cancerous potential of Persistent Rhombic Lip (PeRL)

November 29, 2023 / Cancer
Medulloblastomas are one of the most common types of childhood brain cancer. Thanks to Dr. Sriram Venneti, MD, PhD and his colleagues, there has been a recent breakthrough in group-3 and group-4 medulloblastomas, a tumor that appears during fetal development of the cerebellum.  Alongside collaborating investigators Dr. Elaine Mardis, PhD, Nationwide Children’s Hospital, and Dr. Michael Taylor, MD, PhD Texas Children’s Hospital,
FULL STORY
/static/apps/cms/news/1435/Untitled-1.png

Faculty Recognition: Congratulations!

November 14, 2023 / Award

Multiple Department of Pathology faculty members have recently been recognized for their achievements and nominated to leadership roles for their excellence within their respective fields. These members continue to demonstrate the depth of our department's knowledge and research.

FULL STORY
/static/apps/cms/news/1430/Camelo-Piragua, Sandra  (500 × 500 px).jpg

Sandra Camelo-Piragua, MD recognized for her expertise by the American Board of Pathology

June 12, 2023 / Anatomic Pathology

The American Board of Pathology announced today that our own Dr. Sandra Camelo-Piragua, Professor of Neuropathology and Director of the Neuropathology Fellowship Program, has been named to the Test Development and Advisory Committee for Neuropathology. The full text of their press release is below.  Please join us in congratulating Dr. Camelo-Piragua on this honor.

FULL STORY
/static/apps/cms/news/1230/images/banners/Neuropathology-Header-LG.jpg

Careers in Pathology: Neuropathology Fellowship

March 2, 2022 / Careers In Pathology

Hear from Dr. Emile Pinarbasi, an Anatomic and Neuropathology Fellow within the Department of Pathology.

FULL STORY
/static/apps/cms/news/1217/YIR_500x500.jpg

Year in Review: 2021

January 31, 2022 / Anatomic Pathology

Last year was an eventful time within the Department of Pathology at Michigan Medicine. As we reminisce about 2021, let's revisit some of the greatest memories [...]

FULL STORY
/static/apps/cms/news/1206/images/banners/Anuska-Header-LG.jpg

From Chaos to Balance

January 3, 2022 / Experimental Pathology

Dr. Anuska Andjelkovic-Zochowski's story

FULL STORY

Research Surrounding H3K27M-mutant diffuse midline glioma in COVID-19 Published

July 7, 2020 / Forensics

New research related to H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in young adults with COVID-19 from the Department of Pathology was just published in Acta Neurologica. [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/959/500.jpg

Study from Lieberman Lab Published in Acta Neuropathologica

April 28, 2020 / Publications
 

A new study from the Andrew Lieberman Laboratory’s Samir Nath, et al, has discovered that MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.

Kennedy’s Disease, also known as Spinal and Bulbar Muscular Atrophy (SBMA), is a disease caused by an inherited gene mutation that results in muscle and brain cell dysfunction. Patients progressively lose muscle mass until they are unable to walk without assistance. Ultimately [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/886/Venneti_Lab_Chan.jpg

Dr. Chan Chung Receives Two Grants to Study Brain Cancers

January 9, 2020 / Grants
 

Chan Chung, PhD, received two grants in funding from the ChadTough Foundation and Defeat DIPG foundation ($150,000) and the Robert Connor Dawes CERN Pediatric Fellowship ($100,000). [...]

FULL STORY

Faculty Spotlight: Sean Ferris, MD, PhD

December 10, 2019 / Neuropathology

In September of 2019, Sean Ferris, MD, PhD, moved his family from San Francisco to Ann Arbor to join the Department of Pathology as an assistant professor specializing in neuropathology in the division of anatomic pathology. [...]

FULL STORY
/static/apps/cms/news/513/Venetti-Blog-Article-Header-LG.jpg

DIPG Tumor Patterns Offer New Insight on Survival

January 22, 2018 / Experimental Pathology
An analysis of several hundred DIPG and related tumors, including of Chad Carr,
finds an overlooked key factor in determining prognosis
for the aggressive childhood brain cancer.
FULL STORY
/static/apps/cms/505/Andrew-Lieberman-featured1.jpg

Andrew Lieberman, MD, PhD Elected to National Neuropathology Core Steering Committee

December 19, 2017 / Experimental Pathology

Andrew Lieberman, MD, PhD, Gerald D. Abrams Collegiate Professor and Director of Neuropathology, has been elected to serve on the Neuropathology Core Steering Committee of the National Alzheimer’s Coordinating Center (NACC). The goal of the [...]

FULL STORY

Dr. Sriram Venneti Receives Sontag Foundation Distinguished Scientist Award

November 3, 2017 / Award
Sriram Venetti. MD, PhD, was awarded a $600,000 Sontag Foundation Distinguished Scientist Award grant over a period of 4 years to support his research in cancer metabolism and epigenetics in childhood ependymomas [...]
FULL STORY

Rual Lab Publishes in The EMBO Journal

October 19, 2017 / Pathology News
 
 
A team led by Drs. Tao Xu and Sung-Soo Park in the Jean-Francois Rual Lab shows that the methyl‐lysine reader L3MBTL3 switches the Notch coactivator RBPJ to a [...]
FULL STORY
/static/apps/cms/news/405/venneti-lab-article-header.jpg

Understanding Pediatric Brain Cancer

June 12, 2017 / Newsletter
Dr. Sriram Venneti's lab explores the interface of metabolism, epigenetics and brain development in
order to better understand and eventually treat childhood cancer.
FULL STORY

Sriram Venneti receives ASCI young Physician-Scientist Award

April 20, 2017 / Experimental Pathology
Sriram Venneti, MD, PhD, was awarded the American Society for Clinical Investigation Council Young Physician-Scientist Award. This award was initiated in 2013 and recognizes young physician-scientists who are supported by NIH K or similar significant career-development awards, are early in their first faculty appointment, and have made notable achievements in their research.
FULL STORY
/static/apps/cms/news/371/sandra-fac-spotlight-header.jpg

Collaboration Leads to Time-Saving Microscopic Imaging Technique

February 28, 2017 / Anatomic Pathology
Anatomic Pathology—Sandra Camelo-Piragua, MD
FULL STORY

Award allows junior faculty to focus on research

July 21, 2016 / Award

Assistant Professor Sriram Venneti, M.D., Ph.D. is one of 17 recipients of the Doris Duke Charitable Foundation’s 19th Clinical Scientist Development Awards. The awards are designed to allow junior faculty protected time for their clinical research as they establish their own research programs.

FULL STORY

Dr. Venneti named Kimmel Scholar for his cancer research efforts

April 22, 2016 / Announcement

Assistant Professor, Sriram Venneti, MD, PhD, was named a Kimmel Scholar by the Sidney Kimmel Foundation. The Kimmel Scholar Awards are given annually to 15 innovative research scientists and medical doctors in the U.S. who are in the early stages of their careers. Dr. Venneti will receive a $200,000 grant for his work, titled, “Metabolic regulation of epigenetics in childhood brain tumors.” Congratulations, Dr. Venneti, on being recognized as one of the country’s most promising young cancer researchers!

umhsheadlines.org

FULL STORY
/static/apps/cms/news/280/zika_virus_header.jpg

Triaging Zika Virus in Pathology

March 24, 2016 / Pathology News
The Aedes mosquito. Source - Wikipedia Over the past several months, the Zika virus has prompted the Pan American Health Organization to issue an alert and the World Health Organization to declare a public health emergency. To date, testing for Zika cannot be done on a local level, requiring the Department of Pathology to triage potential cases. Zika virus is most often spread to humans by the bite of an Aedes species mosquito that is infected
FULL STORY

Molecules and Machines

September 23, 2015 / Experimental Pathology

The 2nd Annual Protein Folding Diseases Initiative Symposium, “Molecules and Machines”, was held on Friday, September 18, 2015, at the A. Alfred Taubman Biomedical Science Research Building. 

The University of Michigan Protein Folding Diseases Initiative (PFDI), lead by Drs. Andrew Lieberman and Henry Paulson, seeks to connect the diverse campus-wide expertise on disorders of abnormal protein accumulation and perturbations in “protein quality control.” 

FULL STORY